(Q38803537)

6 September 2017

1 reference

title

Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region (English)

1 reference

6 September 2017

1 reference

3

Po-Ren Hsueh

1 reference

6 September 2017

He Wang

1

1 reference

PubMed ID

27750452

6 September 2017

Ying-Chun Xu

series ordinal

2

1 reference

PubMed ID

27750452

6 September 2017

language of work or name

1 reference

18 October 2016

1 reference

6 September 2017

17

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

6 September 2017

11

1 reference

6 September 2017

1461-1477

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

6 September 2017

1 reference

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Epidemiology of invasive fungal diseases among patients with haematological disorders in the Asia-Pacific: a prospective observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Changing aetiology of healthcare-associated bloodstream infections at three medical centres in Taiwan, 2000-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Emergence of nosocomial candidemia at a teaching hospital in Taiwan from 1981 to 2000: increased susceptibility of Candida species to fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Antifungal susceptibilities of Candida isolates causing bloodstream infections at a medical center in Taiwan, 2009-2010

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Changing epidemiology of candidemia in a medical center in middle Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Distribution of Candida species isolated from blood cultures in hospitals in Osaka, Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Antifungal susceptibility of Candida isolates at one institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Multicenter surveillance of species distribution and antifungal susceptibilities of Candida bloodstream isolates in South Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Antifungal susceptibilities of bloodstream isolates of Candida species from nine hospitals in Korea: application of new antifungal breakpoints and relationship to antifungal usage

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

In vitro antifungal susceptibilities of Candida isolates from patients with invasive candidiasis in Kuala Lumpur Hospital, Malaysia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Predictors and outcomes of Candida bloodstream infection: eight-year surveillance, western Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Epidemiology and identification of potential fungal pathogens causing invasive fungal infections in a tertiary care hospital in northeast Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Invasive candidiasis in Pakistan: clinical characteristics, species distribution and antifungal susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Changing trends of Candidemia and antifungal susceptibility pattern in a tertiary health care centre

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Invasive candidiasis in intensive care units in China: a multicentre prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

New clonal strain of Candida auris, Delhi, India

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Multidrug-resistant endemic clonal strain of Candida auris in India.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

First three reported cases of nosocomial fungemia caused by Candida auris

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne colorimetric method.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole for six Candida species as determined by the colorimetric Sensititre YeastOne method

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Clinical characteristics and treatment outcomes of patients with candidaemia due to Candida parapsilosis sensu lato species at a medical centre in Taiwan, 2000-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Clinical features of patients with infections caused by Candida guilliermondii and Candida fermentati and antifungal susceptibility of the isolates at a medical centre in Taiwan, 2001-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Antifungal susceptibility patterns, in vitro production of virulence factors, and evaluation of diagnostic modalities for the speciation of pathogenic Candida from blood stream infections and vulvovaginal candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Species distribution and drug susceptibility of candida in clinical isolates from a tertiary care centre at Indore.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Candida infection in the intensive care unit: A study of antifungal susceptibility pattern of Candida species in Milad hospital, Tehran, Iran

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

In vitro susceptibility of Candida species to four antifungal agents assessed by the reference broth microdilution method.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Update on antifungal resistance in Aspergillus and Candida.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Echinocandin Resistance in Candida

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Antifungal drug resistance in Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Antifungal drug resistance mechanisms in pathogenic fungi: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Clinical perspectives on echinocandin resistance among Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Genetic and phenotypic characterization of Candida albicans strains isolated from infectious disease patients in Shanghai.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

CaNdt80 is involved in drug resistance in Candida albicans by regulating CDR1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

Antifungal drug resistance among Candida species: mechanisms and clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0099

21 January 2018

Identifiers

DOI

10.2217/FMB-2016-0099

1 reference

6 September 2017

1 reference

PubMed ID

27750452